Suppr超能文献

睾酮替代疗法。

Testosterone replacement therapy.

机构信息

Andrology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

出版信息

Andrology. 2020 Nov;8(6):1551-1566. doi: 10.1111/andr.12774. Epub 2020 Mar 9.

Abstract

BACKGROUND

The aim of testosterone replacement therapy (TRT) is to improve symptoms and signs of testosterone deficiency including decreased libido, erectile dysfunction, depressed mood, anaemia, loss of muscle and bone mass, by increasing serum testosterone levels to physiologic range. TRT has been used in the last 70 years, and overtime, numerous preparations and formulations have been developed to improve pharmacokinetics (PKs) and patient compliance. The routes of delivery approved for use in the Western world include buccal, nasal, subdermal, transdermal and intramuscular (IM).

OBJECTIVES

The aim of this narrative review was to describe and compare all available and approved testosterone preparations according to pharmacology, PKs and adverse effects.

MATERIALS AND METHODS

We have performed an extensive PubMed review of the literature on TRT in clinical practice. Contraindications and monitoring of TRT were analyzed by comparing available guidelines released in the last five years. We provide a review of advantages and disadvantages of different modalities of TRT and how to monitor treatment to minimize the risks.

RESULTS

TRT is associated with multiple benefits highly relevant to the patient. However, the recommendations given in different guidelines on TRT are based on data from a limited number of randomized controlled trials (RCTs), as well as non-randomized clinical studies and observational studies. This is the case for the safety of a long-term TRT in late-onset hypogonadism (LOH). No evidence is provided indeed on the effects of TRT on endpoints such as deterioration of heart failure suggesting a cautious approach to T replacement in older men with a history of heart failure.

CONCLUSION

Clinicians must consider the unique characteristics of each patient and make the necessary adjustments in the management of LOH in order to provide the safest and most beneficial results.

摘要

背景

睾酮替代疗法(TRT)的目的是通过将血清睾酮水平提高到生理范围内,改善睾酮缺乏的症状和体征,包括性欲下降、勃起功能障碍、情绪低落、贫血、肌肉和骨量减少。TRT 已经使用了 70 多年,随着时间的推移,已经开发出许多制剂和配方来改善药代动力学(PKs)和患者依从性。在西方世界批准使用的给药途径包括口腔、鼻腔、皮下、透皮和肌肉内(IM)。

目的

本叙述性综述的目的是描述和比较根据药理学、PKs 和不良反应所有可用和批准的睾酮制剂。

材料和方法

我们对临床实践中 TRT 的文献进行了广泛的 PubMed 综述。通过比较过去五年发布的可用指南,分析了 TRT 的禁忌症和监测。我们回顾了不同 TRT 方式的优缺点以及如何监测治疗以最小化风险。

结果

TRT 与许多对患者非常重要的益处相关。然而,不同指南中关于 TRT 的建议是基于有限数量的随机对照试验(RCT)以及非随机临床研究和观察性研究的数据。这就是迟发性性腺功能减退症(LOH)长期 TRT 的安全性的情况。实际上,没有证据表明 TRT 对心力衰竭等终点的影响,这表明对于有心力衰竭病史的老年男性,在更换 T 时应采取谨慎的方法。

结论

临床医生必须考虑每位患者的独特特征,并在管理 LOH 方面进行必要的调整,以提供最安全和最有益的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验